Enyedy; Istvan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Enyedy; Istvan.The latest application filed is for "imidazo[1,2-a]pyridinyl derivatives as irak4 inhibitors".
- Enyedy; Istvan - Milton MA
- Enyedy; Istvan - Hamden CT
- Enyedy; Istvan - Mount Ranier MD
| Patent | Date |
|---|---|
| Imidazo[1,2-a]pyridinyl Derivatives As Irak4 Inhibitors App 20220089592 - Hopkins; Brian T. ; et al. | 2022-03-24 |
| Nrf2 Activator App 20220048884 - Capacci; Andrew George ; et al. | 2022-02-17 |
| Nrf2 Activator App 20210340107 - Lucas; Brian Stuart ; et al. | 2021-11-04 |
| NRF2 activator Grant 10,968,181 - Lucas , et al. April 6, 2 | 2021-04-06 |
| Nrf2 Activator App 20190389836 - Capacci; Andrew George ; et al. | 2019-12-26 |
| Nrf2 Activator App 20190345112 - Lucas; Brian ; et al. | 2019-11-14 |
| Matriptase, a serine protease and its applications Grant 7,960,163 - Dickson , et al. June 14, 2 | 2011-06-14 |
| 2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents App 20080293696 - Brennan; Catherine ; et al. | 2008-11-27 |
| Matriptase, A Serine Protease And Its Applications App 20080248566 - Dickson; Robert B. ; et al. | 2008-10-09 |
| ErbB-2 selective small molecule kinase inhibitors Grant 7,427,689 - Wang , et al. September 23, 2 | 2008-09-23 |
| Matriptase, a serine protease and its applications Grant 7,355,015 - Dickson , et al. April 8, 2 | 2008-04-08 |
| Erbb-2 selective small molecule kinase inhibitors App 20040023957 - Wang, Shaomeng ; et al. | 2004-02-05 |
| Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions Grant 6,677,377 - Lin , et al. January 13, 2 | 2004-01-13 |
| Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions App 20030092752 - Lin, Chen-Yong ; et al. | 2003-05-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 